EN
Home/Guides/Getting a prescription
Guide 6 of 9 · Stage: Do it safely

Getting a prescription in the UK, and the medicines

First the prescription: the NHS routes in each nation, what you pay, and the rules online pharmacies must follow. Then the medicines: what's licensed, fakes, storage and the official list prices.

The short answer

GLP-1 medicines are prescription-only in the UK. You can get one on the NHS if you meet its criteria, which are strict and differ by nation, or privately from a registered prescriber, often through an online pharmacy. Online services must check your weight by video, in person or from your records. Prescriptions cost £9.90 an item in England and are free in Scotland, Wales and Northern Ireland. Talk to a doctor before starting, stopping or changing any medicine.

Key facts

Prescription
Always. Prescription-only medicines, not sold over the counter.1
NHS England
Mounjaro from a GP for priority groups, in stages; Wegovy for weight only in a specialist service2,3
Online
Your weight must be checked by video, in person, or from your records; a questionnaire alone is not enough17,18
£NHS charge
£9.90 an item in England (free with a diabetes exemption); free in Scotland, Wales and Northern Ireland12,13,14,15,16
£List price
Mounjaro £133 to £330 for 4 weekly doses (one pen) since 1 September 2025, before VAT. Private prices are set by each service2,35
Fakes
A fake Mounjaro pen reached patients through one UK online pharmacy in 202632
On this page
  1. Who can prescribe a GLP-1 in the UK?
  2. How do I get one on the NHS?
  3. What does an NHS prescription cost?
  4. What rules do private and online services follow?
  5. How do I check an online pharmacy?
  6. What should a proper consultation include?
  7. What are the red flags?
  8. Questions to ask a provider
  9. Which GLP-1 medicines are licensed, and for what?
  10. Brand or generic: what's the difference?
  11. Pen or tablet?
  12. How do I spot a fake, and store it right?
  13. What are the official list prices?
  14. What does a year cost?
  15. Questions people ask
1See a registered prescriber: your GP, an NHS service, or a private one
2Your history, and your weight checked properly
3A prescription for a UK-licensed medicine
4A registered pharmacy, a checked pack, kept cold
5Follow-up while the dose goes up, and a review at 6 months

The order this guide follows. The prescriber comes first; the medicine comes second.

Part AGetting a prescription

Who can prescribe a GLP-1 in the UK?

Any registered prescriber, within the rules. In practice there are two routes: the NHS, or a private service you pay for.

All GLP-1 medicines are prescription-only medicines in the UK.1 Prescribers include doctors and some pharmacists and nurses who have trained as independent prescribers. Online pharmacies may use a pharmacist prescriber.18

On the NHS, who prescribes depends on the medicine and where you live: your GP for Mounjaro in England's priority groups, or a specialist weight management service for Wegovy.2,3 Privately, a prescriber may prescribe within the licence: a BMI of 30 or more, or 27 to 29.9 with a weight-related condition.23,24

The UK regulator's review found that most people get these medicines privately: "Access to weight management medicines is usually via private services."19

How do I get one on the NHS?

It depends on which of the four nations you live in. In each, the NHS bar is much higher than the licence.

NationRoutes we found
EnglandMounjaro through GPs, opening in stages from June 2025, starting with a BMI of 40 or more and 4 named conditions. You must take part in a support programme on food and activity.2,10 Wegovy and Saxenda for weight only in a specialist weight management service; Wegovy for up to 2 years.3 Wegovy to lower heart risk in people with heart or circulation disease and a BMI of 27 or more, from May 2026.4
ScotlandMounjaro accepted for adults with a BMI of 30 or more and at least one weight-related condition. Each health board organises its own service.6
WalesMounjaro through specialist weight management services, and since October 2025 also for set groups, such as people waiting for time-sensitive surgery or a transplant.7
Northern IrelandNot available for obesity on the Health Service as of April 2025, with a phased introduction planned. We found no newer official update.8

For type 2 diabetes, GLP-1 medicines are prescribed by your GP or diabetes team. NICE's 2026 guidance says to consider one for people living with obesity once their first diabetes medicines have had at least 3 months.5

Don't book about Mounjaro unless your area says to. Some local NHS areas contact eligible patients directly and ask people not to book GP appointments about it unless invited.9 If you already pay privately, the same NHS criteria apply to you.2 Guide 4 sets out each nation's thresholds, including the lower ones for some ethnic groups.

What does an NHS prescription cost?

Nothing in Scotland, Wales or Northern Ireland. £9.90 an item in England, unless you're exempt. One pen counts as one item.

NationWhat you pay
England£9.90 per item. A prepayment certificate covers all your prescriptions: £32.05 for 3 months or £114.50 for 12 months.12 People with diabetes (unless treated by diet alone) can get a medical exemption certificate and pay nothing.13
ScotlandFree.14
WalesFree, if you're registered with a GP in Wales.15
Northern IrelandFree for everyone.16

Private prescriptions are different. You pay the full price the service charges, and free-prescription rules and exemptions don't apply.

What rules do private and online services follow?

Since February 2025, an online prescriber must check your weight and history for themselves before supplying a weight-loss medicine. A questionnaire alone is not enough.

The General Pharmaceutical Council (GPhC) regulates pharmacies in England, Scotland and Wales. Its 2025 guidance treats weight-loss medicines as "high-risk" when sold at a distance.17 The prescriber:

  • Can't rely on an online form alone. They have to check what you tell them through two-way contact, your medical records, or your GP.17
  • Must check your weight, height or BMI before supplying, by a video consultation, in person, from your clinical records, or by contacting your GP or another healthcare provider.17,18
  • Can't use a phone call to check it. A photo or pre-recorded video from you is not enough on its own either. Photos may be used for repeat supplies, once your weight was first checked another way.18
  • Should tell your regular prescriber, such as your GP, with your consent. If they can't check your details, they should point you to another care provider instead.18

The rules matter because problems are common. Between January 2024 and December 2025, the GPhC received 1,307 concerns about weight-loss medicines. About a quarter were about prescribing.19

Why we don't name any seller. UK law bans advertising prescription-only medicines to the public.22 We explain the rules and how to check a provider; we don't list, rank or price any pharmacy or clinic. Guide 7 explains the types of provider and what to check.

How do I check an online pharmacy?

Look it up on the official register. In Great Britain that's the GPhC; in Northern Ireland, the Pharmaceutical Society of Northern Ireland (PSNI).21

  1. Find the registration number and the pharmacy's address on its website.
  2. Search the GPhC register. It shows whether a pharmacy is registered.21 For Northern Ireland, use the PSNI's register.21
  3. Check the details match: the name, the address and that the registration is current.
No EU logo? That's normal in Great Britain. Since 1 January 2021, online sellers in England, Scotland and Wales no longer have to show the EU common logo for selling medicines online. Sellers in Northern Ireland still must, and must be registered with the MHRA.20 So in Great Britain, the register is your check, not the logo.

What should a proper consultation include?

Questions about your health and medicines, your weight checked properly, and a plan for follow-up.

There's no single official checklist for a GLP-1 consultation. This list brings together what the GPhC rules, NICE and the medicines' labels say a prescriber should check.17,3,36

  • Your history. The US label rules these medicines out if you or your family have had medullary thyroid cancer, or you have MEN 2 (multiple endocrine neoplasia type 2, a rare inherited condition). Tell your doctor if this applies.36 Past pancreatitis or gallstones matter too.36
  • Your other medicines. Insulin, or diabetes tablets like gliclazide, can cause low sugar (hypos) when combined with a GLP-1.36 The dose of those may need to drop.
  • Your weight, checked. By video, in person or from your records, not just typed into a form.18 If your family background is South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean, NICE uses lower BMI thresholds.11 Guide 1 explains the numbers.
  • Eyes, if you have diabetes. The label warns about worse eye disease (retinopathy) in people who already have it.36
  • Pregnancy and contraception. Stop semaglutide at least 2 months, and tirzepatide at least 1 month, before trying to get pregnant. On Mounjaro, add a condom to the pill for 4 weeks after starting and after each dose increase.1
  • Any surgery or procedure coming up. These medicines slow how fast the stomach empties, so food can still be there under anaesthetic. Tell the team doing the procedure that you take one.36
  • A follow-up plan. Who you contact with side effects, and a review at 6 months: NICE says to consider stopping Wegovy if you've lost less than 5% of your weight by then.3

What are the red flags with a pharmacy, clinic or app?

Walk away if you can't check who they are, if nobody checks your weight properly, or if the medicine comes from social media or a salon.

  • Not on the registerPharmacies in Great Britain must be registered with the GPhC, and in Northern Ireland with the PSNI.21
    Shows its registration number and address, and both check out on the register.
  • Just a questionnairePrescribing on an online form alone breaks the GPhC's rules for weight-loss medicines.17
    Checks your weight by video, in person or from your records, and asks to tell your GP.18
  • "Send us a photo" or a quick callA phone call, or a photo alone, isn't an acceptable first weight check.18
    A live video or in-person check the first time.
  • Social media, a salon, or "no prescription needed"The MHRA says never to buy these medicines from beauty salons or through social media.1
    Supplied only by a registered pharmacy, after a clinical assessment.21
  • A powder to mix, or a "research" productPowder-in-vial GLP-1 products are not authorised in the UK.1 Retatrutide is unlicensed, and the MHRA has seized illegal pens of it.34
    A UK-licensed pen or tablet in its sealed pack.
  • Ads for "weight-loss jabs"Prescription-only medicines can't be advertised to the public, and terms like "weight-loss injection" count even without a brand name.22
    Offers a consultation first; the medicine is discussed only after it.

Questions to ask a provider

Take these to the consultation. A good prescriber will be glad you asked.

  1. Who is the prescriber, and what is the pharmacy's GPhC (or PSNI) registration number?
  2. How will you check my weight, and will you tell my GP?
  3. Do I meet the licence criteria for this medicine, and why?
  4. Could I get it on the NHS where I live instead?
  5. What else should I try first or alongside it?
  6. Which side effects should make me contact you, and how do I reach you?
  7. How will my dose go up, and who decides each step?
  8. Does it affect my other medicines, my contraception or a pregnancy plan?
  9. What will it cost per month at the full dose, and what happens if prices change?
  10. What happens when I stop, and how long would I take it?
Part BThe medicines in the UK

Before you go further

  • Prescription only. Never start one without a prescriber.1
  • Know the risks first. Guide 5: Side effects and risks.
  • No promise of results. Weight loss varies a lot from person to person, and some people lose little.

We list brands and official prices as facts. We don't recommend any brand, company or seller, and we earn nothing from them.

Which GLP-1 medicines are licensed in the UK, and for what?

Five medicines. Semaglutide, tirzepatide and orforglipron have brands for weight; Ozempic, Rybelsus and Trulicity are for type 2 diabetes only.

The medicine is what works in your body; the brand is the name on the box. Paracetamol is a medicine; Panadol and Calpol are brands of it. One medicine can have several brands, each licensed for different uses.1

Diabetes licensed for type 2 diabetes Weight licensed for weight management

  • Wegovy injectionWeight23
    Weekly pen; Novo NordiskAlso licensed to lower heart risk (2024), for teens 12 and over who weigh more than 60 kg, and for a scarring fatty liver disease, MASH (2026). A 7.2 mg dose was added in 2026.23,28
  • Wegovy tabletsWeight25
    Daily tablet; licensed June 2026
  • OzempicDiabetes1
    Weekly penNot licensed for weight loss in the UK. Using a medicine outside its licence is called "off-label".1
  • RybelsusDiabetes1
    Daily tablet
  • MounjaroDiabetesWeight24
    Weekly KwikPen; Eli LillyZepbound, its US weight brand, isn't sold in the UK; Mounjaro covers both uses here.24
MedicineOrforglipron
  • FoundayoDiabetesWeight26
    Daily tablet; Eli Lilly; licensed August 2026Unlike the others, it isn't a peptide (a small protein). It can be taken at any time of day, with no food or water rules.26
  • SaxendaWeight27
    Daily pen
  • Generic liraglutideDiabetesWeight30
    Daily pen; several brandsLicensed use depends on the brand: some for weight, some for diabetes.1
  • TrulicityDiabetes31
    Weekly pen

Brand or generic: what's the difference?

A generic is the same medicine made by another company once the patent ends. In the UK, only liraglutide has generics so far.30

The Electronic Medicines Compendium, which holds the official UK product information, lists six generic liraglutide brands: Biolide, Diavic, Liraglutide Biocon, Nevolat, Plaobes and Zegluxen (alphabetical, not a ranking).30 The MHRA says liraglutide is sold under various brand names and its licensed use is brand-specific.1

We found no UK-licensed generic semaglutide or tirzepatide. Anything sold as one in the UK is not a licensed product.30,1

Switching between brands is a prescriber's decision. Pens of different brands can come in different strengths.

Pen or tablet: does it matter?

UK-licensed GLP-1 injections come in pre-filled pens that measure the dose for you. Tablets need a strict routine, which differs by brand.

A pre-filled injection pen with its cap off and a separate pen needlePenPre-filled, dose setA Wegovy FlexTouch or Mounjaro KwikPen holds 4 weekly doses. The Wegovy 7.2 mg pen holds one dose.23,24,28 Never share a pen, even with a new needle.36
A tablet, a glass with a little water, a clock showing a half-hour wait and an empty plateTabletDaily, with brand-specific rulesWegovy tablets: swallow whole after fasting for at least 8 hours, with a sip of water, then no food or drink for at least 30 minutes.25 Foundayo: any time of day, with no food or water rules.26
Vials are a warning sign in the UK. The MHRA says GLP-1 products sold as a powder in a vial, to be mixed before injecting, are not authorised.1 If you think you've injected too much, or have severe stomach pain that won't go away, call 999 or go to A&E. For urgent advice that isn't an emergency, use NHS 111.36

How do I spot a fake, and store it right?

Fake pens have been found in the UK, including one supplied through an online pharmacy. Only use a pack from a registered pharmacy, against your prescription.32,33

In October 2023, the MHRA warned that fake Ozempic and Saxenda pens had been found in the UK.33 In February 2026, it warned of a fake Mounjaro KwikPen 15 mg, batch D873576, supplied through one UK online pharmacy. It was noticed because the dose knob came off while in use.32

In October 2025, the MHRA found the UK's first illegal factory making weight-loss pens, and seized more than 2,000 unlicensed retatrutide and tirzepatide pens.34

Check the pack when it arrives

Something wrong? Don't use it. Keep the pen and packaging, tell the pharmacy, and report it to the MHRA's Yellow Card scheme. Guide 5 explains how.

Keep it cold

The single-dose Wegovy 7.2 mg pen can be kept out of the fridge for up to 28 days at up to 30°C.29 Tablets need no fridge; keep them in their blister pack. Check your own pack leaflet.

What are the official list prices?

For Mounjaro, £133 to £330 for 4 weekly doses (one pen), depending on the dose, since 1 September 2025. These are list prices before VAT, not what a private service charges you.2,35

A list price is what the maker charges, published by NICE in its appraisals. The NHS pays a confidential discount.2,3 Private services set their own prices, which usually include their consultation and delivery, so they differ from these figures and from each other. We don't show sellers' prices.

Mounjaro (tirzepatide), weekly pen

StrengthPer pen (4 weekly doses)
2.5 mg£133.00
5 mg£180.00
7.5 mg and 10 mg£255.00
12.5 mg and 15 mg£330.00

NICE TA1026, section 2.3, excluding VAT. Checked 12 Oct 2026.2

Wegovy (semaglutide), weekly FlexTouch pen

StrengthPer pen (4 weekly doses)
0.25, 0.5 and 1 mg£73.25
1.7 mg£124.53
2.4 mg£175.80

NICE TA875, section 2.3, excluding VAT, published March 2023. We could not find a newer official list price. Checked 12 Oct 2026.3

How to read these prices
  • Each price is for one pen of 4 weekly doses, about a month.2,3
  • Mounjaro's list price rose on 1 September 2025. Before, it was £92 to £122 a pen. At the top doses it went from £122 to £330, almost 2.7 times as much. Lilly said it was addressing "pricing inconsistencies" with other developed countries, and that it had agreed continued supply with the NHS.35
  • Not published: we found no official UK list price for the Wegovy 7.2 mg pen, Wegovy tablets or Foundayo.
  • Diabetes medicines such as Ozempic, Rybelsus and Trulicity aren't in these tables. On the NHS, people with diabetes in England can get an exemption and pay nothing for prescriptions.13

What does a year cost?

On the NHS, little or nothing. Privately, the medicine alone at list price comes to between about £2,300 and £3,800 a year for Mounjaro, depending on your dose. Private services set their own prices.

Work out your own cost

Choose a medicine. The cost calculator adds up the dose steps for 6 or 12 months at current prices, and you can change the plan.

Opens the cost calculator in a new tab. Nothing you choose leaves your device.

On the NHS. A year of weekly pens is 13 items. In England that's £128.70 at £9.90 each, or £114.50 with a 12-month prepayment certificate. It's free with a diabetes exemption, and free in Scotland, Wales and Northern Ireland.12,13,14,15,16

Privately, at list price. Here is a worked example for Mounjaro, using the list prices above. We count 6 months as 26 weekly doses and 12 months as 52. The UK label starts at 2.5 mg for 4 weeks, then goes to 5 mg; after that, the dose can rise by 2.5 mg at a time, at least 4 weeks apart, up to 15 mg.24 This is an example for the sum, not a suggestion; your prescriber decides your dose.

Mounjaro, at list price6 months12 months
Staying on 5 mg (4 weeks at 2.5 mg, then 5 mg)£1,123£2,293
Rising to 15 mg (4 weeks at each step, then 15 mg)£1,648£3,793

Staying on 5 mg: one 2.5 mg pen (£133), then 5 mg at £180 a pen (£45 a dose): 22 more doses by 6 months (£990) and 48 by 12 months (£2,160). Rising to 15 mg: one pen each of 2.5, 5, 7.5, 10 and 12.5 mg for the first 20 weeks (£133 + £180 + £255 + £255 + £330 = £1,153), then 15 mg at £330 a pen (£82.50 a dose): 6 more doses by 6 months (£495) and 32 by 12 months (£2,640). List prices exclude VAT and any service fees.2,24

Budget in years, not months: Guide 9 covers what happens when you stop. We found no UK private medical insurer that confirmed it covers these medicines; check your own policy in writing before you count on it.

The risks, in brief

  • Feeling sick, vomiting, diarrhoea and constipation are common, mostly when the dose goes up.36
  • Inflamed pancreas (pancreatitis): severe stomach pain that won't settle.36
  • Gallbladder problems, including gallstones.36
  • Losing too much fluid from vomiting or diarrhoea can harm the kidneys.36
  • The US label rules it out for people with medullary thyroid cancer in themselves or their family, or with MEN 2; tell your doctor if this applies.36
  • Not in pregnancy. Stop semaglutide at least 2 months, and tirzepatide at least 1 month, before trying.1
Read Guide 5: Side effects and risks →

Questions people ask

Can my GP prescribe Mounjaro for weight loss?

In England, yes, if you're in a priority group that has opened, starting with a BMI of 40 or more and 4 named conditions. Groups open in stages.2 Some areas will contact you if you're eligible.9 Scotland, Wales and Northern Ireland have their own rules; see the NHS routes.

Can my GP prescribe Wegovy?

Not for weight in England: NICE recommends it only within a specialist weight management service, which your GP can refer you to.3 A newer NICE recommendation covers Wegovy for people with heart or circulation disease and a BMI of 27 or more.4

Is it safe to get Mounjaro or Wegovy online?

It can be, from a registered pharmacy that follows the rules. Check the pharmacy on the GPhC register (or the PSNI's in Northern Ireland), and expect your weight to be checked by video, in person or from your records.21,18 Never buy from social media or a beauty salon.1

Are weight-loss jabs free in Scotland, Wales and Northern Ireland?

NHS prescriptions are free there.14,15,16 But you still have to meet NHS criteria, and access is limited.6,7,8 A private prescription is paid in full wherever you live.

Is Ozempic licensed for weight loss in the UK?

No. In the UK, Ozempic and Rybelsus are licensed for type 2 diabetes only. Wegovy is the semaglutide brand licensed for weight management.1

Is Zepbound available in the UK?

No. In the UK, tirzepatide is sold as Mounjaro, licensed for both type 2 diabetes and weight management.24

Can I keep the pen out of the fridge?

Unused pens go in the fridge. After first use, a Wegovy FlexTouch can be kept below 30°C for up to 6 weeks, and a Mounjaro KwikPen at up to 30°C for up to 30 days.23,24 Check your own pack leaflet.

Before you move on

  • Check whether you fit an NHS route where you live.
  • Online is fine from a registered pharmacy that checks your weight by video, in person or from your records.
  • Look the pharmacy up on the GPhC register (PSNI in Northern Ireland).
  • Only UK-licensed pens or tablets: never a powder to mix, or anything from social media.
  • If you pay privately, budget for the full dose and for years, not the starting price.
Was this guide easy to understand?

Sources

  1. MHRA (UK medicines regulator). GLP-1 medicines for weight loss and diabetes: what you need to know (prescription-only; licensed uses by brand, including Ozempic and Rybelsus for diabetes only; liraglutide brand-specific; powder-in-vial products not authorised; don't buy from beauty salons or social media; pregnancy and contraception). Published 5 June 2025, updated 5 February 2026. GOV.UK
  2. NICE. Tirzepatide for managing overweight and obesity (TA1026), 23 December 2024: recommendations, section 2.3 (list prices for a 4-week supply, excluding VAT: £133.00 for 2.5 mg, £180.00 for 5 mg, £255.00 for 7.5 mg and 10 mg, £330.00 for 12.5 mg and 15 mg), section 2.4 (confidential NHS discount), section 4 (phased NHS rollout). NICE
  3. NICE. Semaglutide for managing overweight and obesity (TA875), 8 March 2023: recommendations 1.1 and 1.2 (specialist services only, maximum 2 years, consider stopping if less than 5% lost after 6 months), section 2.3 (list prices per pack of 1 pen delivering 4 doses, excluding VAT), section 2.4 (confidential discount). NICE
  4. NICE. Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and overweight or obesity (TA1152), 7 May 2026. NICE
  5. NICE. Type 2 diabetes in adults: management (NG28), updated 18 February 2026: recommendation 1.29.2. NICE
  6. Scottish Medicines Consortium. Tirzepatide (Mounjaro) for weight management, SMC2653. 2024. SMC
  7. Welsh Government. People waiting for time-sensitive surgery to get weight-loss drugs on the NHS. 23 October 2025. GOV.WALES
  8. Northern Ireland Formulary (Health and Social Care). Patient information leaflet: tirzepatide (Mounjaro) for obesity. April 2025. NI Formulary
  9. NHS South West London Integrated Care Board. Tirzepatide (Mounjaro) for weight loss ("You will be contacted directly if you are eligible"). Updated 30 July 2026. Link
  10. NHS South West London Integrated Care Board. Tirzepatide position statement, version 4, June 2025 (wraparound care required). PDF
  11. NICE. Overweight and obesity management (NG246), 14 January 2025, updated 8 January 2026: recommendation 1.9.11 (lower BMI thresholds for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean background). NICE
  12. NHS Business Services Authority. NHS prescription prepayment certificate (PPC) (£9.90 per item; PPC £32.05 for 3 months, £114.50 for 12 months). Checked 12 October 2026. NHSBSA
  13. NHS Business Services Authority. Medical exemption certificates ("diabetes mellitus, except where treatment is by diet alone"). Checked 12 October 2026. NHSBSA
  14. NHS inform (Scotland). Prescription charges and exemptions ("Prescriptions in Scotland are free"). Checked 12 October 2026. NHS inform
  15. Welsh Government. Free prescriptions ("If you are registered with a GP in Wales you are entitled to free prescriptions from a pharmacist in Wales"). Checked 12 October 2026. GOV.WALES
  16. nidirect (Northern Ireland). Help with health costs ("All prescriptions dispensed in Northern Ireland are free of charge for everyone"). Checked 12 October 2026. nidirect
  17. General Pharmaceutical Council. Online pharmacies strengthen safeguards to prevent unsafe supply of medicines (guidance for pharmacies providing services at a distance; weight-management medicines; prescriber must independently verify weight, height and/or BMI). 4 February 2025. GPhC
  18. General Pharmaceutical Council. Providing weight management services: FAQs (verification by video, in person, clinical records or contacting the GP; "Verifying information through a phone call would not be appropriate"; photographs; sharing information with the regular prescriber). Checked 12 October 2026. GPhC
  19. General Pharmaceutical Council. Weight management medicines and services: a review of GPhC inspections and concerns (1,307 concerns, January 2024 to December 2025; prescribing 27%). April 2026. PDF
  20. MHRA. Register for the EU common logo ("From 1 January 2021 Great Britain (England, Wales and Scotland) based online sellers are no longer required to display the EU common logo"; Northern Ireland sellers still must). Updated 23 October 2025. GOV.UK
  21. MHRA. MHRA urges public to avoid illegal online weight loss medicines this New Year (check Great Britain pharmacies on the GPhC website and Northern Ireland pharmacies with the PSNI; supply only after a clinical assessment). 29 December 2025. GOV.UK
  22. Advertising Standards Authority / CAP. Weight control: prescription-only medicines (CAP Code rule 12.12; terms such as "weight-loss injection" count as promoting a POM). ASA
  23. Novo Nordisk. Wegovy 2.4 mg FlexTouch, UK summary of product characteristics, sections 4.1, 6.3, 6.4 (licensed uses; 4 doses per pen; storage). Electronic Medicines Compendium, revised September 2026. emc
  24. Eli Lilly. Mounjaro KwikPen, UK summary of product characteristics, sections 4.1, 4.2, 6.3, 6.4 ("Each KwikPen contains 4 doses"; dose steps; after first use, "unrefrigerated for up to 30 days at a temperature not above 30 °C"). Electronic Medicines Compendium, revised 29 August 2026. emc
  25. MHRA. First GLP-1 tablet for weight loss approved in the UK (Wegovy tablets; fasting and 30-minute rules). 11 June 2026. GOV.UK
  26. MHRA. UK first in Europe to authorise orforglipron for weight management and type 2 diabetes (Foundayo; "can be taken at any time of day with no food or water restrictions"). 10 August 2026. GOV.UK
  27. Novo Nordisk. Saxenda, UK summary of product characteristics, section 4.1. Electronic Medicines Compendium. emc
  28. MHRA. Single-dose 7.2 mg semaglutide (Wegovy) pen approved to treat adult patients with obesity. 14 April 2026. GOV.UK
  29. Novo Nordisk. Wegovy 7.2 mg single-dose pen, UK summary of product characteristics, section 6.4 (may be kept unrefrigerated up to 28 days at up to 30°C). Electronic Medicines Compendium. emc
  30. Electronic Medicines Compendium. Search results for "liraglutide" (Biolide, Diavic, Liraglutide Biocon, Nevolat, Plaobes, Zegluxen, Saxenda; no generic semaglutide or tirzepatide listed). Checked 12 October 2026. emc
  31. Eli Lilly. Trulicity, UK summary of product characteristics, section 4.1 (type 2 diabetes). Electronic Medicines Compendium. emc
  32. MHRA. Drug Safety Update: falsified Mounjaro (tirzepatide) KwikPen 15 mg pre-filled pens. 24 February 2026. GOV.UK
  33. MHRA. MHRA warns of unsafe fake weight loss pens. 26 October 2023. GOV.UK
  34. MHRA. MHRA smashes major illicit weight loss medicine production facility in record seizure. 24 October 2025. GOV.UK
  35. The Pharmaceutical Journal. Reimbursement for NHS Mounjaro dispensing confirmed for September 2025 (cost prices of £92–122 rising from 1 September 2025 to £133 for 2.5 mg and £330 for 12.5 mg and 15 mg; Lilly on "pricing inconsistencies"; agreement with the NHS on supply). 28 August 2025. Link
  36. Novo Nordisk. Wegovy (semaglutide) US prescribing information, revised June 2026: contraindications, warnings, overdose, patient counselling. PDF

Last checked 12 Oct 2026 · NHS access and prices re-checked monthly · Next full review due Jan 2027 · Report an error

How this guide was made. Written by the GLP Guidebook team from the sources above: MHRA, NICE, GPhC and NHS guidance in each nation, UK product information and named trade press. It's general information, not medical advice. Talk to a qualified doctor before starting, stopping or changing any medicine. In an emergency, call 999. We don't sell, prescribe or recommend any brand, and we take no money from drug companies, pharmacies or clinics. How we write